Methyl Sinapate (Phenolic Ester)

Methyl sinapate is a phenolic ester compound found naturally in certain plants, particularly mustard seeds and canola oil. Current evidence is limited to preclinical studies showing interactions with MAPK/ERK and NF-κB signaling pathways.

Category: Compound Evidence: 4/10 Tier: Preliminary (in-vitro/animal)
Methyl Sinapate (Phenolic Ester) — Hermetica Encyclopedia

Origin & History

Methyl sinapate is a natural phenylpropanoid compound classified as a phenolic ester (C₁₂H₁₄O₅, molecular weight 238.24) found in the herbs of Rauvolfia tetraphylla. It is commercially available as a high-purity (≥98%) solid, often synthesized or isolated for research purposes.

Historical & Cultural Context

No historical or traditional medicinal uses of methyl sinapate are documented in available sources. The compound has not been associated with any traditional medicine systems such as Ayurveda or TCM.

Health Benefits

• No clinically proven health benefits - evidence limited to preclinical studies only
• Associated with increased chromosome aberrations in cells (preliminary evidence)
• Linked to multiple biochemical pathways including MAPK/ERK and NF-κB in research contexts (mechanism studies only)
• May interact with PI3K/Akt/mTOR and neuronal signaling pathways (theoretical, no clinical evidence)
• No human studies available to confirm any therapeutic effects

How It Works

Methyl sinapate appears to modulate the MAPK/ERK signaling pathway, which regulates cell proliferation and differentiation. The compound also interacts with NF-κB pathways involved in inflammatory responses. However, preliminary evidence suggests it may increase chromosome aberrations in cellular studies, indicating potential genotoxic effects.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses on methyl sinapate have been identified. Research is limited to in vitro or preclinical studies examining its association with chromosome aberrations and biochemical pathway interactions.

Clinical Summary

No human clinical trials have been conducted on methyl sinapate supplementation. Available research consists entirely of in vitro cell culture studies and animal models examining its biochemical effects. Preliminary cellular studies have raised safety concerns due to observed increases in chromosome aberrations. The lack of clinical data makes it impossible to establish efficacy or safe dosing parameters for human use.

Nutritional Profile

Methyl Sinapate is a phenolic ester compound (methyl ester of sinapic acid), not a nutritional ingredient and therefore carries no meaningful macronutrient or micronutrient profile in the dietary sense. Molecular formula: C12H14O5, molecular weight: 238.24 g/mol. Bioactive compound classification: hydroxycinnamic acid derivative (phenylpropanoid family), structurally characterized by a methoxylated and hydroxylated cinnamic acid backbone esterified with a methyl group. Contains two methoxy groups (-OCH3) at the 3 and 5 positions and one hydroxyl group (-OH) at the 4 position of the aromatic ring. Protein content: 0g. Fat content: 0g. Carbohydrate content: 0g. Fiber: 0g. Caloric value: negligible/not applicable as a food ingredient. Naturally occurring trace concentrations found in Brassica species (mustard, rapeseed, canola) and related plant sources, typically at sub-milligram per gram levels in plant tissue. Bioavailability: limited data available; as a phenolic ester, subject to esterase hydrolysis in the gastrointestinal tract potentially releasing sinapic acid as the primary bioactive metabolite. Lipophilicity (logP estimated ~1.5–2.0) suggests moderate membrane permeability. No established dietary reference intake, no RDA, and no recognized role as an essential nutrient. Antioxidant capacity attributed to the phenolic hydroxyl group, consistent with other sinapate esters, though quantitative ORAC or DPPH values specific to methyl sinapate in food matrices are not established in published literature.

Preparation & Dosage

No clinically studied dosage ranges have been established for methyl sinapate as no human clinical trials exist. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Not applicable - no established therapeutic use

Safety & Interactions

Methyl sinapate shows concerning preliminary evidence of increased chromosome aberrations in cell studies, suggesting potential genotoxic effects. No human safety data exists, and interactions with medications are unknown due to lack of clinical research. Pregnant and breastfeeding women should avoid this compound due to insufficient safety information. The compound's effects on drug metabolism pathways remain unstudied.